Usefulness of carbon-11-labeled methionine positron-emission tomography for assessing the treatment response of primary central nervous system lymphoma
Usefulness of carbon-11-labeled methionine positron-emission tomography for assessing the treatment response of primary central nervous system lymphoma
复制标题
碳 11 标记蛋氨酸正电子发射断层扫描在评估原发性中枢神经系统淋巴瘤治疗反应中的用途
DOI:
10.1093/jjco/hyaa010
复制
发表时间:
2020
影响因子:
2.4
通讯作者:
Narita Yoshitaka
中科院分区:
文献类型:
--
作者:
Miyakita Yasuji;Ohno Makoto;Takahashi Masamichi;Kurihara Hiroaki;Katai Hitoshi;Narita Yoshitaka
Background: Primary central nervous system lymphoma (PCNSL) responds relatively quickly to chemotherapy or radiotherapy. However, determination of a complete response (CR) after treatment is often difficult because of extremely light residual contrast enhancement on magnetic resonance images due to the effects of microhemorrhages and scar tissue formation. These small enhancing lesions define an unconfirmed complete response (CRu). The aim of this study was to investigate the usefulness of carbon-11-labeled methionine (11C-Met) positron-emission tomography (PET) for determining the treatment response of PCNSL.Methods: Data for 36 patients who were treated for PCNSL between 2011 and 2015 and underwent MRI and 11C-Met PET were reviewed. MRI findings were classified as CR, CRu, and tumor mass (TM; a composite of partial response, stable disease, and progressive disease). PET images were evaluated, standardized uptake values were quantified, and the tumor to normal tissue count ratio (TNR) was calculated. Receiver operating characteristic curves were generated to determine the optimal cut-off TNRs.Results: The optimal TNRs for differentiating CR and CRu from TM were 1.83 (area under the curve [AUC], 0.951) and 1.80 (AUC, 0.932), respectively. The corresponding sensitivity and specificity values for the diagnosis of TM were 82.4% and 100%, respectively, in the CR group and 85.3% and 85%, respectively, in the CRu group.Conclusions: A TNR of≥ 1.80 can aid in the detection of active PCNSL using 11C-Met PET. Thus, 11C-Met-PET may be a useful tool for accurate evaluation of the treatment efficacy in PCNSL.